Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Recent Advances in the Treatment of Cerebellar Disorders.

Mitoma H, Manto M, Gandini J.

Brain Sci. 2019 Dec 23;10(1). pii: E11. doi: 10.3390/brainsci10010011. Review.

2.

Association of daily physical activity with cognition and mood disorders in treatment-naive patients with early-stage Parkinson's disease.

Terashi H, Taguchi T, Ueta Y, Mitoma H, Aizawa H.

J Neural Transm (Vienna). 2019 Dec;126(12):1617-1624. doi: 10.1007/s00702-019-02085-x. Epub 2019 Sep 30.

PMID:
31571008
3.

Contribution of the Cerebellum to Predictive Motor Control and Its Evaluation in Ataxic Patients.

Kakei S, Lee J, Mitoma H, Tanaka H, Manto M, Hampe CS.

Front Hum Neurosci. 2019 Jun 26;13:216. doi: 10.3389/fnhum.2019.00216. eCollection 2019.

4.

The Classification of Autosomal Recessive Cerebellar Ataxias: a Consensus Statement from the Society for Research on the Cerebellum and Ataxias Task Force.

Beaudin M, Matilla-Dueñas A, Soong BW, Pedroso JL, Barsottini OG, Mitoma H, Tsuji S, Schmahmann JD, Manto M, Rouleau GA, Klein C, Dupre N.

Cerebellum. 2019 Dec;18(6):1098-1125. doi: 10.1007/s12311-019-01052-2. Review.

5.

Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study.

Iijima M, Orimo S, Terashi H, Suzuki M, Hayashi A, Shimura H, Mitoma H, Kitagawa K, Okuma Y.

Expert Opin Pharmacother. 2019 Aug;20(11):1405-1411. doi: 10.1080/14656566.2019.1614167. Epub 2019 May 28.

PMID:
31039621
6.

Critical Thinking and Scientific Writing Skills of Non-Anglophone Medical Students: a Model of Training Course.

Barroga E, Mitoma H.

J Korean Med Sci. 2019 Jan 4;34(3):e18. doi: 10.3346/jkms.2019.34.e18. eCollection 2019 Jan 21. Review.

7.

Improving Scientific Writing Skills and Publishing Capacity by Developing University-Based Editing System and Writing Programs.

Barroga E, Mitoma H.

J Korean Med Sci. 2018 Dec 28;34(1):e9. doi: 10.3346/jkms.2019.34.e9. eCollection 2019 Jan 7. Review.

8.

Task Force Paper On Cerebellar Transplantation: Are We Ready to Treat Cerebellar Disorders with Cell Therapy?

Cendelin J, Buffo A, Hirai H, Magrassi L, Mitoma H, Sherrard R, Vozeh F, Manto M.

Cerebellum. 2019 Jun;18(3):575-592. doi: 10.1007/s12311-018-0999-1. Review.

PMID:
30607797
9.

The Era of Cerebellar Therapy.

Mitoma H, Manto M.

Curr Neuropharmacol. 2019;17(1):3-6. doi: 10.2174/1570159X1701181129111212.

10.

Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?

Manto M, Mitoma H, Hampe CS.

Cerebellum. 2019 Apr;18(2):153-156. doi: 10.1007/s12311-018-0986-6.

11.

Cerebellar Cortex as a Therapeutic Target for Neurostimulation.

van Dun K, Mitoma H, Manto M.

Cerebellum. 2018 Dec;17(6):777-787. doi: 10.1007/s12311-018-0976-8. Review.

PMID:
30276522
12.

Consensus paper: Decoding the Contributions of the Cerebellum as a Time Machine. From Neurons to Clinical Applications.

Bareš M, Apps R, Avanzino L, Breska A, D'Angelo E, Filip P, Gerwig M, Ivry RB, Lawrenson CL, Louis ED, Lusk NA, Manto M, Meck WH, Mitoma H, Petter EA.

Cerebellum. 2019 Apr;18(2):266-286. doi: 10.1007/s12311-018-0979-5.

PMID:
30259343
13.

Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.

Mitoma H, Manto M, Hampe CS.

Curr Neuropharmacol. 2019;17(1):33-58. doi: 10.2174/1570159X16666180917105033. Review.

14.

Characteristics of apathy in treatment-naïve patients with Parkinson's disease.

Terashi H, Ueta Y, Kato H, Mitoma H, Aizawa H.

Int J Neurosci. 2019 Jan;129(1):16-21. doi: 10.1080/00207454.2018.1503184. Epub 2018 Nov 29.

PMID:
30035696
15.

Editorial: Advances in Therapies of Cerebellar Disorders.

Mitoma H, Manto M.

CNS Neurol Disord Drug Targets. 2018;17(3):157-160. doi: 10.2174/187152731703180619151532. No abstract available.

PMID:
29992874
16.

Neurotransplantation therapy.

Cendelin J, Mitoma H.

Handb Clin Neurol. 2018;155:379-391. doi: 10.1016/B978-0-444-64189-2.00025-1. Review.

PMID:
29891073
17.

Metabolic ataxias.

Ismail FY, Mitoma H, Fatemi A.

Handb Clin Neurol. 2018;155:117-127. doi: 10.1016/B978-0-444-64189-2.00008-1. Review.

PMID:
29891054
18.

Time Is Cerebellum.

Mitoma H, Manto M, Hampe CS.

Cerebellum. 2018 Aug;17(4):387-391. doi: 10.1007/s12311-018-0925-6.

19.

Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head.

Sakamoto Y, Yamamoto T, Sugano N, Takahashi D, Watanabe T, Atsumi T, Nakamura J, Hasegawa Y, Akashi K, Narita I, Miyamoto T, Takeuchi T, Ikari K, Amano K, Fujie A, Kubo T, Tada Y, Kaneuji A, Nakamura H, Miyamura T, Kabata T, Yamaji K, Okawa T, Sudo A, Ohzono K, Tanaka Y, Yasunaga Y, Matsuda S, Imai Y; Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head, Akiyama M, Kubo M, Kamatani Y, Iwamoto Y, Ikegawa S.

Sci Rep. 2017 Nov 8;7(1):15035. doi: 10.1038/s41598-017-14778-y.

20.

Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson's Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance.

Iijima M, Mitoma H, Uchiyama S, Kitagawa K.

Front Neurol. 2017 Oct 24;8:542. doi: 10.3389/fneur.2017.00542. eCollection 2017.

Supplemental Content

Loading ...
Support Center